ATEZOLIZUMAB

atezolizumab 1.875 g/15 mL injection, 15 mL vial

ATEZOLIZUMAB (14298M)

atezolizumab 1.875 g/15 mL injection, 15 mL vial
14298M
Body System:
Manner of administration:Injection
Section 100 (CT)
Authority Required (STREAMLINED)

Restriction  18326

Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Initial treatment 1

Restriction  10125

Indication: Stage IV (metastatic) non-small cell lung cancer (NSCLC)
Treatment phase: Initial treatment 2
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 1 # of repeats: 5 DPMQ: $6,747.37 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Tecentriq SC